New ultrasonographic markers of aneuploidies: Nasal bones

Ultrasound Review of Obstetrics and Gynecology

Volumn 2, Issue 4, 2002, Pages 229-234

  Monni, G ^a   Zoppi, M A ^a  

^a Osp Regionale per le Microcitemie   (Italy)

Author keywords

Nasal bones; Nuchal translucency; Trisomy 21 screening

Indexed keywords

ANEUPLOIDY; BONE DEVELOPMENT; BONE RADIOGRAPHY; DIAGNOSTIC ACCURACY; FACE MALFORMATION; FEMALE; FETUS; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GENETIC SCREENING; HISTOPATHOLOGY; HUMAN; NECK MUSCLE; PRENATAL SCREENING; REVIEW; SECOND TRIMESTER PREGNANCY; TRISOMY; TRISOMY 18; TRISOMY 21; TRISOMY 9; TURNER SYNDROME;

EID: 0036891597     PISSN: 14722240     EISSN: None     Source Type: Journal    
DOI: 10.1080/14722240208500480     Document Type: Review

References (46)

1. Benacerraf BR. The second-trimester fetus with Down syndrome: detection using sonographic features. Ultrasound Obstet Gynecol 1996;7:147-55
2. Jones KL. Smith's Recognizable Patterns of Human Malformation. Philadelphia: WB Saunders, 1988:10-19
3. Benacerraf BR, Barss VA, Laboda LA. A sonographic sign for the detection in the second trimester of the fetus with Down's syndrome. Am J Obstet Gynecol 1985;151:1078-9
4. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency screening for chromosomal defects in first trimester of pregnancy. Br Med J 1992;304:867-9
5. Smidt-Bindman R, Hosmer W, Feldstein V, Deeks JJ, Goldberg J. Second trimester ultrasound to detect fetuses with Down syndrome: a meta analysis. J Am Med Assoc 2001;285:1044-55
6. Snijders RJM, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet 1998;352:343-6
7. Zoppi MA, Ibba RM, Putzolu M, Floris M, Monni G. Assessment of risk for chromosomal abnormalities at 10-14 weeks of gestation by nuchal translucency and maternal age in 5210 fetuses carried out at a single center. Fetal Diagn Ther 2000;15:170-3
8. Zoppi MA, Ibba RM, Putzolu M, Floris M, Monni G. Nuchal translucency and the acceptance of invasive prenatal chromosomal diagnosis in women aged 35 and older. Obstet Gynecol 2001;97:916-20
9. Zoppi MA, Ibba RM, Floris M, Monni G. Fetal nuchal translucency screening in 12 495 pregnancies in Sardinia. Ultrasound Obstet Gynecol 2001;18:649-51
10. Salomon LJ, Bernard JP, Taupin P, Benard C, Ville Y. Relationship between nuchal translucency at 11-14 weeks and nuchal fold at 20-24 weeks of gestation. Ultrasound Obstet Gynecol 2001;18:636-7
11. Moscoso G. Fetal nuchal translucency: a need to understand the physiological basis. Ultrasound Obstet Gynecol 1995;5:6-8
12. Von Kaisenberg CS, Brand-Saberi B, Jonat W, Nicolaides KH. Pathophysiology of increased nuchal translucency in chromosomally abnormal fetuses. Prenat Neonat Med 1999;4:431-40
13. Hyett J, Moscoso G, Nicolaides K. Abnormalities of the heart and great arteries in first trimester chromosomally abnormal fetuses. Am J Med Genet 1997; 17:207-16
14. Souka AP, Krampl E, Bakalis S, Heath V. Nicolaides KH. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol 2001;18:5-8
15. von Kaisenberg CS, Krenn V, Ludwig M, Nicolaides KH, Brand Saberi B. Morphological classifiation of nuchal skin in human fetuses with trisomy 21, 18, and 13 at 12-18 weeks and in a trisomy 16 mouse. Anat Embryol 1998;197:105-24
16. von Kaisenberg CS, Brand-Saberi B, Christ B, Vallian S, Farzaneh F, Nicolaides KH. Collagen type VI gene expression in the skin of trisomy 21 fetuses. Obstet Gynecol 1998;91:319-23
17. Bohlandt S, von Kaisenberg CS, Wewetzler K, Christ B, Nicolaides KH, Brand-Saberi B. Hyaluronan in the nuchal skin of chromosomally abnormal fetuses. Hum Reprod 2000;15:1155-8
18. Monni G, Zoppi MA, Ibba RM, Floris M. Fetal nuchal translucency test for Down's syndrome. Lancet 1997; 350:1631
19. Chasen ST, Skupsi DW, McCullogh LB, Chervenak FA. Prenatal informed consent for sonogram: the time for first trimester nuchal translucency has come. J Ultrasound Med 2001;20:1147-52
20. Spencer K, Souter V, Tul N, Snijders R, Nicolaides K. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 1999;13:231-7
21. Wald NJ, Watt HC, Hackshaw AK. Integrated screening for Down's syndrome on the basis of test performed during the first and second trimesters. N Engl J Med 1999;12:461-7
22. Matias A, Montenegro N. Ductus venosus blood flow in chromosomally abnormal fetuses at 11 to 14 weeks of gestation. Semin Perinatol 2001;25:32-7
23. Zoppi MA, Putzolu M, Ibba RM, Floris M, Monni G. First trimester ductus venosus velocimetry in relation to nuchal translucency thickness and fetal karyotype. Fetal Diagn Ther 2002;17:52-7
24. Stempfle N, Huten Y, Fredouille C, Brisse H, Nessmann C. Skeletal abnormalities in fetuses with Down's syndrome: a radiographic post-mortem study. Pediatr Radiol 1999;29:682-8
25. Fitzsimmons J, Droste S, Shepard TH, Pascoe-Mason J, Chinn A, Mack LA. Long-bone growth in fetuses with Down syndrome. Am J Obstet Gynecol 1989; 161:1174-7
26. Lockwood C, Benacerraf B, Krinsky A, et al. A sonographic screening method for Down syndrome. Am J Obstet Gynecol 1987;157:803-8
27. Benacerraf BR, Osathanondh R, Frigoletto FD. Sonographic demonstration of hypopolasia of the middle phalanx of the fifth digit, a finding associated with Down syndrome. Am J Obstet Gynecol 1988; 159:181-3
28. Goldstein I, Gomez K, Copel JA. Fifth digit measurement in normal pregnancies, a potential sonographic sign of Down's syndrome. Ultrasound Obstet Gynecol 1995;5:34-7
29. Mortensson W, Hall B. Abnormal pelvis in newborn infants with Down's syndrome. Acta Radiol 1972; 12:847-55
30. Zoppi MA, Ibba RM, Floris M, Monni G. Can fetal iliac bone measurement be used as a marker for Down's syndrome screening? Ultrasound Obstet Gynecol 1998;12:19-22
31. Keeling JW, Fisher Hansen B, Kjaer I. Pattern of malformations in the axial skeleton in human trisomy 21 fetuses. Am J Med Genet 1997;68:466-71
32. Kjaer I, Keeling JW, Reintoft I, Nolting D, Fisher Hansen B. Pituitary gland and sella turcica in human trisomy 21 fetuses related to axial skeletal development. Am J Med Genet 1998;80:494-500
33. Mooney MP, Siegel MI. Understanding Craniofacial Anomalies. New York: Wiley-Liss, 2002:50-4
34. Sandikcioglou M, Molsted K, Kjaer I. The prenatal development of the human nasal and vomeral bones. J Craniofac Genet Dev Biol 1994;14:124-34
35. Ibba RM, Zoppi MA, Floris M, et al. Otocephaly: prenatal diagnosis of a new case and etiopathogenetic considerations. Am J Med Genet 2000;90:427-9
36. Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides KH. Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study. Lancet 2001;358:1665-7
37. Sonek J, Nicolaides K. Prenatal ultrasound diagnosis of nasal bone abnormalities in three fetuses with Down syndrome. Am J Obstet Gynecol 2002;186: 139-41
38. Guis F, Ville Y, Vincent Y, Doumerc S, Pons JC, Frydman R. Ultrasound evaluation of the length of the fetal nasal bones throughout gestation. Ultrasound Obstet Gynecol 1995;5:304-7
39. Cicero S, Bindra G, Rembouskos G, Tripsanas C, Nicolaides KH. Fetal nasal bone length in chromosomally normal and abnormal fetuses at 11-14 weeks of gestation. J Maternal Fetal Neonat Med 2002;11: 400-2
40. Monni G, Zoppi MA, Ibba RM. Absence of nasal bone and detection of trisomy 21. Lancet 2002;359:1343
41. Monni G, Zoppi MA, Ibba RM, Floris M, Manca F, Axiana C. Absence of nasal bone and aneuploidies at 11-14 weeks in an unselected population. 2002; in press
42. De Biasio P, Venturini PL. Absence of nasal bone and detection of trisomy 21. Lancet 2002;359:1344
43. Cuckle H. Time for total shift to first trimester screening for Down's syndrome. Lancet 2001;358:1658-9
44. Kjaer I, Keeling JW, Fisher Hansen B. Pattern of malformations in the axial skeleton in human trisomy 18 fetuses. Am J Med Genet 1996;65:332-6
45. Hjalgrim H, Hahnemann JM, Kjaer I, Broendum-Nielsen K. Absence of nasal bone and detection of trisomy 21. Lancet 2002;359:1343-4
46. Hjalgrim H, Fisher Hansen B, Brondum-Nielsen K, Nolting D, Kjaer I. Aspect of skeletal development in fragile X syndrome fetuses. Am J Med Genet 2000; 95:123-9